These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Safety of Typhim Vi vaccine in a postmarketing observational study. Marcus LC, Froeschle JE, Hill DR, Wolfe MS, Maus D, Connor B, Acosta AM, Rensimer ER, Roberts A, Dardick K. J Travel Med; 2007; 14(6):386-91. PubMed ID: 17995534 [Abstract] [Full Text] [Related]
5. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults. Beeching NJ, Clarke PD, Kitchin NR, Pirmohamed J, Veitch K, Weber F. Vaccine; 2004 Nov 15; 23(1):29-35. PubMed ID: 15519704 [Abstract] [Full Text] [Related]
7. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. Green MS, Cohen D, Lerman Y, Sjogren M, Binn LN, Zur S, Slepon R, Robin G, Hoke C, Bancroft W. Isr J Med Sci; 1994 Nov 15; 30(5-6):485-8. PubMed ID: 8034508 [Abstract] [Full Text] [Related]
8. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years. Overbosch D, Peyron F, Picot N, Varichon JP, Dumas R, Chambonneau L, Weber F. J Travel Med; 2005 Nov 15; 12(6):319-26. PubMed ID: 16343383 [Abstract] [Full Text] [Related]
10. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine]. Gil A, González A, Dal-Ré, Aguilar L, Malo C, del Rey J. Med Clin (Barc); 1994 May 28; 102(20):769-71. PubMed ID: 8041214 [Abstract] [Full Text] [Related]
11. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children. Kanra G, Yalçin SS, Ceyhan M, Yurdakök K. Turk J Pediatr; 2000 May 28; 42(2):105-8. PubMed ID: 10936974 [Abstract] [Full Text] [Related]
12. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults. Alberer M, Burchard G, Jelinek T, Reisinger E, Beran J, Hlavata LC, Forleo-Neto E, Dagnew AF, Arora AK. J Travel Med; 2015 May 28; 22(1):48-56. PubMed ID: 25308927 [Abstract] [Full Text] [Related]
14. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults. Loebermann M, Kollaritsch H, Ziegler T, Rendi-Wagner P, Chambonneau L, Dumas R, Lafrenz M. Clin Ther; 2004 Jul 28; 26(7):1084-91. PubMed ID: 15336473 [Abstract] [Full Text] [Related]
15. Combined vaccination against yellow fever and typhoid fever: a comparative trial. Ambrosch F, Fritzell B, Gregor J, Jonas S, Kollaritsch H, Teulieres L, Wiedermann G. Vaccine; 1994 May 28; 12(7):625-8. PubMed ID: 8085380 [Abstract] [Full Text] [Related]
16. Immunogenicity and reactogenicity of an inactivated hepatitis A vaccine in Indian adults. Das K, Jain A, Gupta RK, Kar P. Natl Med J India; 1999 May 28; 12(6):268-9. PubMed ID: 10732428 [Abstract] [Full Text] [Related]
17. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans. Guan R, Ng HS, Fock KM, Ho KY, Yap I, Kang JY, Chow WC, Chew CN, Ng C, Teo CJ. Southeast Asian J Trop Med Public Health; 1995 Jun 28; 26(2):268-71. PubMed ID: 8629058 [Abstract] [Full Text] [Related]
19. Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air Force recruits. Panchanathan V, Kumar S, Yeap W, Devi S, Ismail R, Sarijan S, Sam SM, Jusoh Z, Nordin S, Leboulleux D, Pang T. Bull World Health Organ; 2001 Jun 28; 79(9):811-7. PubMed ID: 11584728 [Abstract] [Full Text] [Related]
20. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine. Miyazu M, Kikuchi H, Hamada A, Fukushima S, Ouchi K, Bosch Castells V, Mihara H, Bonnet MC. Vaccine; 2015 Nov 27; 33(48):6697-702. PubMed ID: 26518404 [Abstract] [Full Text] [Related] Page: [Next] [New Search]